Perpetual LTD Biogen Inc. Transaction History

Perpetual LTD

$8.28 Trillion
Q1 2025

A detailed history of Perpetual LTD transactions in Biogen Inc. stock. As of the latest transaction made, Perpetual LTD holds 1,797 shares of BIIB stock, worth $218,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,797

Holding current value

$218,874

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 Apr 24, 2025	BUY	$133.43 - $153.27 $239,773 - $275,426	1,797 New	1,797 $246 Million
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $289,656 - $330,051	1,129 New	1,129 $314 Million

Others Institutions Holding BIIB

# of Institutions

1,007

Shares Held

127M

Call Options Held

1.77M

Put Options Held

2.34M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.04 Billion
0.05% of portfolio
Primecap Management CO Pasadena, CA

16M
Shares

$1.95 Billion
1.94% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$1.77 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.4M
Shares

$901 Million
0.05% of portfolio
Geode Capital Management, LLC Boston, MA

3.7M
Shares

$450 Million
0.04% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.

Account